Clinical Trial Update: ICS/LABA Adherence and COPD Exacerbation

View source ↗

Summary

Completed study update on adherence to inhaled corticosteroid/long-acting beta-agonist therapy and its relation to COPD exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED